MoneyWorks4Me

Oxygenta Pharmaceutical informs about RTA certificate

18 Oct 2024 Evaluate
Oxygenta Pharmaceutical has informed about the certificate dated October 03, 2024, issued by Venture Capital and Corporate Investments, Registrar and Transfer Agent of the Company, confirming the compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Second quarter ended on September 30, 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..